Search research articles
Contact Us
Filters
Showing results (1-10 of 178) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2016
Right to know and right to ignore in paediatric oncogenetics: Identifying biological causes, or seeking for meaning?
Franck Bourdeaut
Soins. Pediatrie, Puericulture
|
February 6, 2013
[Genetic predisposition to bone tumors]
Franck Bourdeaut
Neuro-Oncology
|
March 23, 2021
Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
Franck Bourdeaut
Bulletin Du Cancer
|
December 11, 2012
[Chromatin remodeling defects and cancer: the SWI/SNF example]
Franck Bourdeaut, Ivan Bièche
La Revue Du Praticien
|
February 3, 2015
[Biology of cancer and leukemia in childhood]
Arnaud Petit, Franck Bourdeaut
The Lancet. Oncology
|
May 14, 2018
Genetic predisposition to medulloblastomas: just follow the tumour genome
Franck Bourdeaut, Olivier Delattre
The Lancet. Oncology
|
July 3, 2013
Extracranial rhabdoid tumours: what we have learned so far and future directions
Bernadette Brennan, Charles Stiller, Franck Bourdeaut
Medecine Sciences : M/S
|
October 17, 2012
[Subtypes of medulloblastomas: distinct cellular origins]
Franck Bourdeaut, Celio Pouponnot, Olivier Ayrault
Current Opinion in Oncology
|
September 5, 2020
Embryonal tumors of the central nervous system
Mélanie Pagès, Julien Masliah-Planchon, Franck Bourdeaut
Cancer Genetics
|
December 4, 2014
Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013
Franck Bourdeaut, Susan N Chi, Michael C Frühwald
Page
of 18
Search research articles
Search
Showing results (1-10 of 178) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2016
Right to know and right to ignore in paediatric oncogenetics: Identifying biological causes, or seeking for meaning?
Franck Bourdeaut
Soins. Pediatrie, Puericulture
|
February 6, 2013
[Genetic predisposition to bone tumors]
Franck Bourdeaut
Neuro-Oncology
|
March 23, 2021
Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
Franck Bourdeaut
Bulletin Du Cancer
|
December 11, 2012
[Chromatin remodeling defects and cancer: the SWI/SNF example]
Franck Bourdeaut, Ivan Bièche
La Revue Du Praticien
|
February 3, 2015
[Biology of cancer and leukemia in childhood]
Arnaud Petit, Franck Bourdeaut
The Lancet. Oncology
|
May 14, 2018
Genetic predisposition to medulloblastomas: just follow the tumour genome
Franck Bourdeaut, Olivier Delattre
The Lancet. Oncology
|
July 3, 2013
Extracranial rhabdoid tumours: what we have learned so far and future directions
Bernadette Brennan, Charles Stiller, Franck Bourdeaut
Medecine Sciences : M/S
|
October 17, 2012
[Subtypes of medulloblastomas: distinct cellular origins]
Franck Bourdeaut, Celio Pouponnot, Olivier Ayrault
Current Opinion in Oncology
|
September 5, 2020
Embryonal tumors of the central nervous system
Mélanie Pagès, Julien Masliah-Planchon, Franck Bourdeaut
Cancer Genetics
|
December 4, 2014
Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013
Franck Bourdeaut, Susan N Chi, Michael C Frühwald
Page
of 18